Shigeru Nanbara

530 total citations
16 papers, 453 citations indexed

About

Shigeru Nanbara is a scholar working on Immunology, Oncology and Epidemiology. According to data from OpenAlex, Shigeru Nanbara has authored 16 papers receiving a total of 453 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 5 papers in Oncology and 3 papers in Epidemiology. Recurrent topics in Shigeru Nanbara's work include Immune Cell Function and Interaction (11 papers), Immunotherapy and Immune Responses (3 papers) and Immune Response and Inflammation (3 papers). Shigeru Nanbara is often cited by papers focused on Immune Cell Function and Interaction (11 papers), Immunotherapy and Immune Responses (3 papers) and Immune Response and Inflammation (3 papers). Shigeru Nanbara collaborates with scholars based in Japan. Shigeru Nanbara's co-authors include Tsuyoshi Akiyoshi, Masaki Mori, Koshi Mimori, Hideki Inoue, K. Tsuji, Ueo H, G F Barnard, Shinya Arinaga, Tsuyoshi Akiyoshi and Hiroaki Ueo and has published in prestigious journals such as Cancer, Clinical & Experimental Immunology and Cancer Immunology Immunotherapy.

In The Last Decade

Shigeru Nanbara

15 papers receiving 447 citations

Peers

Shigeru Nanbara

ONCOL

MB

SURGE

CR

PRM

Dory Sample United States

Namiko Yada-Hashimoto Japan

Sadanori Fuchimoto Japan

E. Sato Japan

T. Løvig Norway

WM Wong China

Masataka Sasaki Japan

Callum Hall United Kingdom

Yasuhiko Nagata Japan

Sonja Kappel Austria

Dory Sample United States

Shigeru Nanbara

239 ×1.2

ONCOL

161 ×1.3

MB

174 ×1.6

SURGE

133 ×1.4

CR

45 ×0.5

PRM

Citations per year, relative to Shigeru Nanbara Shigeru Nanbara (= 1×) peers Dory Sample

Countries citing papers authored by Shigeru Nanbara

Since Specialization

Citations

This map shows the geographic impact of Shigeru Nanbara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shigeru Nanbara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shigeru Nanbara more than expected).

Fields of papers citing papers by Shigeru Nanbara

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shigeru Nanbara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shigeru Nanbara. The network helps show where Shigeru Nanbara may publish in the future.

Co-authorship network of co-authors of Shigeru Nanbara

This figure shows the co-authorship network connecting the top 25 collaborators of Shigeru Nanbara. A scholar is included among the top collaborators of Shigeru Nanbara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shigeru Nanbara. Shigeru Nanbara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

1.

Hasegawa, Hirofumi, et al.. (1999). An effective pre-operative chemoimmunotherapy regimen against advanced gallbladder carcinoma: a case report.. PubMed. 46(27). 1639–42. 4 indexed citations

2.

Imayama, Shuhei, Masaki Mori, Hiroaki Ueo, et al.. (1996). Presence of elevated carcinoembryonic antigen on absorbent disks applied to nipple area of breast carcinoma patients. Cancer. 78(6). 1229–1234. 7 indexed citations

3.

Imayama, Shuhei, Masaki Mori, Hiroaki Ueo, et al.. (1996). Presence of elevated carcinoembryonic antigen on absorbent disks applied to nipple area of breast carcinoma patients. Cancer. 78(6). 1229–1234.

4.

Arinaga, Shinya, et al.. (1995). Lymphokine‐activated killer cell function of lymphocytes from regional lymph nodes in patients with gastric carcinoma. Journal of Surgical Oncology. 58(1). 44–49. 3 indexed citations

5.

Mori, Masaki, Koshi Mimori, Hideki Inoue, et al.. (1995). Detection of cancer micrometastases in lymph nodes by reverse transcriptase-polymerase chain reaction.. PubMed. 55(15). 3417–20. 320 indexed citations

6.

Honda, Masayuki, Hiroaki Ueo, Hiroshi Inoue, et al.. (1994). Neuroleptic malignant syndrome occurring after an emergency operation for traumatic duodenal perforation: Report of a case. Surgery Today. 24(3). 276–279. 5 indexed citations

7.

Nanbara, Shigeru, et al.. (1994). Lymphokine‐activated killer cell activity of peripheral blood, spleen, regional lymph node, and tumor infiltrating lymphocytes in gastric cancer patients. Journal of Surgical Oncology. 55(3). 179–185. 11 indexed citations

8.

Arinaga, Shinya, Shigeru Nanbara, Hiroshi Inoue, et al.. (1994). Laboratory Correlates of Chemoimmunotherapy with Low-Dose Recombinant Interleukin-2 and Mitomycin C in Patients with Advanced Carcinoma. Cancer Investigation. 12(6). 588–596. 2 indexed citations

9.

Arinaga, Shinya, et al.. (1994). Lymphokine-activated killer cell function of peripheral blood mononuclear cells, spleen cells and regional lymph node cells in gastric cancer patients. Clinical & Experimental Immunology. 96(3). 484–490. 6 indexed citations

10.

Arinaga, Shinya, Masashi Adachi, Hiroshi Inoue, et al.. (1993). Cytotoxic cell function and phenotypic analysis of peripheral blood mononuclear cells in cancer patients treated with low-dose interleukin-2 and mitomycin C. Cancer Immunology Immunotherapy. 37(4). 220–226. 3 indexed citations

11.

Arinaga, Shinya, et al.. (1992). Enhanced production of interleukin 1 and tumor necrosis factor by peripheral monocytes after lentinan administration in patients with gastric carcinoma. International Journal of Immunopharmacology. 14(1). 43–47. 33 indexed citations

12.

Arinaga, Shinya, Shigeru Nanbara, Hiroshi Inoue, et al.. (1992). Enhanced induction of lymphokine-activated killer activity after lentinan administration in patients with gastric carcinoma. International Journal of Immunopharmacology. 14(4). 535–539. 17 indexed citations

13.

Arinaga, Shinya, Shigeru Nanbara, Daisuke Watanabe, et al.. (1992). A trial of adjuvant chemoimmunotherapy with mitomycin c and ok‐432 for stage III gastric carcinoma. Journal of Surgical Oncology. 50(3). 187–189. 6 indexed citations

14.

Arinaga, Shinya, Shigeru Nanbara, Hiroshi Inoué, et al.. (1992). Correlation of eosinophilia with clinical response in patients with advanced carcinoma treated with low-dose recombinant interleukin-2 and mitomycin C. Cancer Immunology Immunotherapy. 35(4). 246–250. 19 indexed citations

15.

Akiyoshi, Tsuyoshi, Shinya Arinaga, Shigeru Nanbara, et al.. (1990). The effect of recombinant interleukin 2 in combination with mitomycin C on advanced cancer. Surgery Today. 20(3). 365–368. 3 indexed citations

16.

Nanbara, Shigeru, Shinya Arinaga, & Tsuyoshi Akiyoshi. (1989). Augmentation of the generation of lymphokine-activated killer cells after a single dose of mitomycin C in cancer patients. Cancer Immunology Immunotherapy. 29(4). 237–41. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact